2025. June 15., Sunday
High contrast Default color scheme
DE
Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar

University of Szeged
Albert Szent-Györgyi Medical School 
Foreign Students' Secretariat




Your Education. Our Mission.

News & Events  --  Lead news

1711465211-pph-temp-rno6n8-jpg-20240326-1280-720-90-cr

State-of-the-art foetal screening centre at the University of Szeged

2024. April 11.

A unique national centre for screening the cardiovascular, neurological and genetic abnormalities of foetuses has been established at the Department of Obstetrics and Gynaecology, University of Szeged.

The new foeto-maternal centre (FMC) will greatly advance obstetric and gynaecological care, bringing about major improvements in the quality of prenatal care.


Foeto-maternal medicine, a novel specialty of only a few decades old, focuses on the diagnosis and management of complicated pregnancies in addition to screening. The field is developing in parallel with ultrasound technology and molecular genetics. The high-power ultrasound equipment required for such screenings first appeared in private care in Hungary in the last two decades. These private providers were pioneers in screening for Down syndrome and cardiovascular conditions in early pregnancy, performing early pregnancy extended ultrasound assessment, non-invasive foetal genetic testing, preterm birth screening, as well as screening for gestational pre-eclampsia.


2

The majority of specialists employed at the new centre used to work in the private sector. However, the knowledge accumulated in private care has its place in public care, and the University of Szeged made this transfer possible. The centre has a digital toolkit unique in public obstetric care in Hungary. Expectant mothers are examined using state-of-the-art ultrasound equipment, two of which are expected to be in operation by the end of the year. The ultrasound device is capable of safely assessing the hermetically sealed nature of a 1-millimetre heart valve in the 7-millimetre heart of a 12-week-old foetus.

The IT system of the centre is capable of real-time data transmission, which also allows for remote consultation and assessment. As a result, pregnant women will be able to receive both still and moving images of their scans.

3

Dr. Szabolcs Várbíró, Head of the Department of Obstetrics and Gynaecology, said that the new approach had enabled the identification of a foetus with hiatal hernia in January 2024. This condition could have had a serious impact on postnatal prognosis, but with the help of the device, doctors were able to evaluate the foetus' condition in utero with great accuracy. The expectant mother has since undergone successful surgery and was discharged three weeks after her arrival.

Targeted brain scans are also part of the centre's professional programme. Neurosonography is a relatively new field, performed by only a handful of doctors in Hungary today, and it is considered a unique test even in wealthier countries. Besides the heart, the brain is the most complex organ of the foetus and the one that makes the most mistakes. A targeted examination of the brain can reveal these abnormalities in brain development. Therefore, an important professional concept of the FMC is the cardio-neuro-genetic approach, which means that these two organ systems are examined in great detail, as they account for about half of all foetal malformations.

4

The FMC also carries out the basic screening of pregnant women at SZTE. The goal of the department is to meet the international ISUOG (International Society of Ultrasound in Obstetrics and Gynecology) recommendations, which far exceed the professional and legal standards in Hungary.

In accordance with the international guidelines of the Fetal Medicine Foundation (FMF), all basic ultrasound screenings at the centre are complemented by screening for preeclampsia and preterm birth without biochemistry. The FMC recommends using the combination of extended ultrasound scan + NIPT (maternal circulating foetal DNA test), which is considered the most reliable worldwide for screening for chromosomal abnormalities.

Latest news

SZTE-MSD_egyuttmukodesi_megallapodas_alairas_2

When Academia and Industry Join Forces: University of Szeged and MSD Establish Joint Department

The University of Szeged and MSD have established a joint Pharmaceutical Industry Partnership Department, marking a new chapter in their collaboration. This initiative builds on a long-standing partnership – further strengthened in 2023 through clinical trial cooperation – and seeks to foster innovation in research, education, and pharmaceutical development. The agreement was officially signed in Szeged by Prof. Dr. László Rovó, Rector of the University of Szeged; Prof. Dr. Ildikó Csóka, Director-General for Strategic Planning; Prof. Dr. Zsolt Szakonyi, Dean of the Faculty of Pharmacy; Sean R. Smith, Managing Director of MSD Pharma Hungary Kft.; and Dr. Szabolcs Barótfi, Director of Clinical Research at MSD Hungary.

Read more

083a6605

Advancing Biomedical Science: Host–Pathogen Interaction Center Inaugurated at the University of Szeged with Support from Alumna and Nobel Laureate Katalin Karikó

On May 12, the University of Szeged held an official ceremony to inaugurate its new research unit: the Host–Pathogen Interaction Center. Located within the Institute of Biology, the Center features Hungary’s only in vivo experimental station of its kind, alongside five newly renovated laboratories. This state-of-the-art facility is designed to support the development of antimicrobial therapies, with a particular focus on antifungal treatments – addressing a pressing yet often overlooked public health concern. The project was made possible through both professional and financial support from Katalin Karikó, an SZTE alumna and recipient of the 2023 Nobel Prize in Physiology or Medicine.

Read more

KJA-Number-0879

SZTE Enters Strategic Partnerships with Leading South American Research Institutions on its 444 Anniversary

The origins of the University of Szeged date back to May 12, 1581, when István Báthory established the Jesuit College in Cluj-Napoca – an institution recognized as SZTE's legal predecessor. Exactly 444 years later, the University marked this anniversary with a symbolic “birthday gift”: the signing of two strategic partnership agreements. Supported by two of South America’s leading scientific and healthcare institutions, these partnerships are set to position SZTE among the global research elite in emerging and internationally significant fields of healthcare research and education.

Read more